Notice Number: NOT-HL-12-160
Key Dates
Release Date: October 19, 2012
RFA-HL-13-023
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
On July 26, 2012, the NHLBI issued a Funding Opportunity Announcement (FOA): RFA-HL-13-023 Career Development Program in Omics of Lung Diseases (K12).
The following two corrections to this FOA are being made:
Part 2. Section II. Award Information
Current Language:
Funding Instrument |
Grant |
Funds Available and Anticipated Number of Awards |
NHLBI intends to commit up to $1,000,000 in FY 2013 and up to $2,250,000 for the subsequent four years to fund up to eight awards. Future year amounts will depend on annual appropriations. Each budget year may not exceed the following direct cost thresholds: Year 1: $115,000, Year 2: $250,000, Year 3: $250,000, Year 4: $250,000 Indirect costs are reimbursed at 8% of modified total direct costs (exclusive of tuition and fees and expenditures for equipment) rather than on the basis of a negotiated rate agreement. |
New Language:
Funding Instrument |
Grant |
Funds Available and Anticipated Number of Awards |
NHLBI intends to commit up to $1,000,000 in FY 2013 and up to $2,250,000 for the subsequent four years to fund up to eight awards. Future year amounts will depend on annual appropriations. Each budget year may not exceed the following direct cost thresholds: Year 1: $115,000, Year 2: $250,000, Year 3: $250,000, Year 4: $250,000, Year 5: $250,000. Indirect costs are reimbursed at 8% of modified total direct costs (exclusive of tuition and fees and expenditures for equipment) rather than on the basis of a negotiated rate agreement. |
Part 2. Full Text of Announcement Section I. Funding Opportunity Description
Current Language:
The scholars will receive $75,000 in salary support plus fringe benefits and $11,500 for research expenses per year for up to 3 years.
New Language:
The scholars will receive up to $75,000 in salary support plus fringe benefits and $11,500 for research expenses per year for up to 3 years.
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Sandra Colombini Hatch, M.D.
Lung Biology and Disease Branch
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Suite 10162, MSC 7952
Bethesda, MD 20892-7952
Phone: (301) 435-0222
Fax: (301) 480-3557
Email: hatchs@nhlbi.nih.gov
and Human Services (HHS)
